United Therapeutics (UTHR)
(Delayed Data from NSDQ)
$261.09 USD
-5.13 (-1.93%)
Updated May 8, 2024 04:00 PM ET
After-Market: $261.08 -0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/7/24 |
---|---|
Current Quarter | 6.13 |
EPS Last Quarter | 6.17 |
Last EPS Surprise | 9.59% |
ABR | 1.50 |
Earnings ESP
|
1.09% |
---|---|
Current Year | 24.20 |
Next Year | 26.74 |
EPS (TTM) | 21.15 |
P/E (F1) | 11.00 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 672.14M | 679.74M | 2.66B | 2.86B |
# of Estimates | 7 | 7 | 7 | 7 |
High Estimate | 696.00M | 723.50M | 2.84B | 3.16B |
Low Estimate | 642.88M | 632.75M | 2.51B | 2.60B |
Year ago Sales | 596.50M | 609.40M | 2.33B | 2.66B |
Year over Year Growth Est. | 12.68% | 11.54% | 14.38% | 7.26% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.13 | 6.21 | 24.20 | 26.74 |
# of Estimates | 9 | 7 | 10 | 10 |
Most Recent Consensus | 6.41 | 7.04 | 25.91 | 26.98 |
High Estimate | 6.50 | 6.92 | 28.89 | 37.65 |
Low Estimate | 5.55 | 5.60 | 21.28 | 21.67 |
Year ago EPS | 5.24 | 5.38 | 19.81 | 24.20 |
Year over Year Growth Est. | 16.98% | 15.43% | 22.16% | 10.51% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 5 | 2 | 6 | 6 |
Up Last 30 Days | 4 | 3 | 5 | 5 |
Up Last 60 Days | 5 | 4 | 7 | 7 |
Down Last 7 Days | 0 | 2 | 1 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 6.13 | 6.21 | 24.20 | 26.74 |
7 Days Ago | 5.86 | 6.12 | 23.64 | 24.78 |
30 Days Ago | 5.85 | 6.10 | 23.77 | 25.09 |
60 Days Ago | 5.77 | 5.97 | 23.15 | 24.12 |
90 Days Ago | 5.47 | 5.52 | 21.94 | 23.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 6.20 | 6.40 | 24.56 | 27.47 |
Zacks Consensus Estimate | 6.13 | 6.21 | 24.20 | 26.74 |
Earnings ESP | 1.09% | 3.09% | 1.49% | 2.70% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 6.17 | 4.36 | 5.38 | 5.24 | NA |
Estimate | 5.63 | 3.92 | 4.89 | 4.41 | NA |
Difference | 0.54 | 0.44 | 0.49 | 0.83 | 0.58 |
Surprise | 9.59% | 11.22% | 10.02% | 18.82% | 12.41% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more